In the Treatment of Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline, multidrug-resistant tuberculosis (MDR-TB) is defined specifically as resistance to at least isoniazid and rifampin. According to the guideline, at least how many medications are recommended during the intensive phase of treatment for patients with MDR-TB?
Better luck next time
The guideline authors recommended that 4 drugs be used during the continuation phase of treatment.
For more bacterial infection content, visit the Resource Center.